• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITHS MEDICAL ASD INC. CLEO INFUSION SET; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITHS MEDICAL ASD INC. CLEO INFUSION SET; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number 21-7221
Device Problems Detachment Of Device Component (1104); Device Operational Issue (2914)
Patient Problem Hyperglycemia (1905)
Event Type  malfunction  
Manufacturer Narrative
Customer has not yet returned the device to the manufacturer for device evaluation.When and if the device becomes available and is returned and evaluated the manufacturer will file a follow-up report detailing the results of the evaluation.
 
Event Description
It was reported that during application, adhesive stuck to the cap.Blood glucose level was impacted as a result and corrected by injection.No adverse health outcome resulted from this event.
 
Manufacturer Narrative
Five opened devices were returned for evaluation.Upon visual examination, the adhesive layer was found to be adhered to the inserter cap (instead of attached to the inserter/retractor as expected).The most likely causes of the reported issue were determined to be: the adhesive pad became detached; either during adhesive application or after white cap assembly or the adhesive pad was received defective from supplier which then allowed for the adhesive to become detached (after visual inspection).To address the two potential root causes identified, the manufacturing facility modified the assembly procedure to include an additional manufacturing step to ensure bonding between the adhesive pad and the inserter/retractor.The manufacturing facility also modified the 100% inspection of the adhesive pad; procedure was modified to include regular verification of alignment of the equipment.These changes were implemented in november 2015.To address the potential for defective adhesive pad, the manufacturing facility notified the adhesive pad supplier and requested an investigation.Supplier verified no issues were identified during manufacturing of the components listed.No further actions were identified by supplier.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLEO INFUSION SET
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
SMITHS MEDICAL ASD INC.
1265 grey fox road
st. paul MN 55112
Manufacturer (Section G)
SMITHS MEDICAL ASD, INC.
1265 grey fox rd.
st. paul MN 55112
Manufacturer Contact
michele seliga
1265 grey fox rd.
st. paul, MN 55112
7633833052
MDR Report Key5438222
MDR Text Key38236538
Report Number2183502-2016-00203
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K042172
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,distributor
Reporter Occupation Patient
Type of Report Initial,Followup
Report Date 02/16/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/16/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date04/28/2020
Device Model Number21-7221
Device Catalogue Number21-7221-24
Device Lot Number75X073
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received04/20/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/07/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-